Wang et al. reported that dihydrotanshinone I can suppress the migration and invasion of ovarian cancer cells in a concentration-dependent manner by downregulating phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) (Wang et al., 2020). The gene discussed is PIK3CA; the disease is ovarian cancer.